RISK FACTORS FOR HEPATOCELLULAR CANCER IN ONCOLOGY PRACTICE The experience of N. N. Blokhin Russian Cancer Research center
Abstract
Aims: To explore the spectrum of risk factors associated with hepatocellular cancer (HCC) in Russian Federation, their prognostic significance for overall survival (OS). Methods: retrospective trial of 380 HCC cases referred to Russian Cancer Research center n. a.N.N.Blokhin between 2005 and 2015. Results: We observed viral hepatitis in 221 (58,2%) pts; liver cirrhosis 203 (53,4%) pts. The most (n=94 from 105 pts) HBs+ cases were men, with cirrhosis in 64,8%. There was men’s (n=82) prevalence in HCV patients (n=114, 30%) also, mostly complicated with cirrhosis (n=100, 87,7%). We didn’t find any HCC-driven risk factors in 59 pts, including 28 pts with fibrolamellar carcinoma. There were 33 pts with alcohol intake as a risk factor. The main risk factors for 66 pts were signs of metabolic-associated diseases. HBV+ (p=0,041, HR=1,36), alcohol intake (р=0,0001, HR=1,75) and smoking (р=0.009, HR=1,52) were significant for OS. Diabetes mellitus, (p=0,03; HR=1,62), TNM stage (p<0,001; HR=1,42), АFP level (p=0,001) and male gender (p=0,024; HR=1,82) negatively correlates with OS worsening. Conclusions: Less than 60% of Russian HCC pts were HBV/HCV carriers or cirrhotic. HBV+ and HCV+ (27,6% and 30% pts); metabolic disorders (17,4%) and alcohol intake (8,7%) were predominant risk factors for HCС We didn’t observe significant OS difference between viral- and nonviral-associated HCC.
About the Author
V. V. Breder
The experience of N. N. Blokhin Russian Cancer Research center
Russian Federation
Russian Federation
References
1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-29.
2. Ferlay J, Soerjomataram I, Ervik M, eds, et al. GLOBOCAN2012: estimated cancer incidence and mortality prevalence worldwide in 2012. http:// globocan.iarc.fr/Default.aspx.
3. Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133-1145.
4. Давыдов М. И., Аксель Е. М.2014 г Статистика злокачественных новообразований в России и странах СНГ в 2012 г. УДК 616-006.04-036.22(47+57):31”2010”Д13.
5. Каприн А. Д., Старинский В. В., Петрова Г. В. (ред). «Состояние онкологической помощи населению России в 2014 году» Москва; 2015 г. МНИОИ им. П. А. Герцена: филиал ФГБУ «Национальный медицинский исследовательский радиологический центр» МЗ РФ Российский Центр информационных технологий и эпидемиологических исследований в области онкологии».
6. Herbst DA, Reddy KR. Risk factors for hepatocellular carcinoma. Clin Liver Dis. 2012;1: 180-182.
7. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991; 325:675-680.
8. Sangiovanni A, Prati GM, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 2006;43:1303-1310.
9. Ioannou G, Splan M, Weiss N, et al. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2007;5:938-945.
10. Патютко Ю. И. Сагайдак И. В. Чучуев Е. С. и соавт. Бюллетень медицинских Интернет-конференций. 2011; том 1, № 6-6.
11. Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.
12. Kanwal F, Hoang T, Kramer JR, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology 2011;140:1182-1188 e1181.
13. Dyson J, Jaques B, Chattopadyhay D, et al. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol 2014; 60: 110-117.
14. Uehara T, Ainslie G. R., Kutanzi K., et al. Molecular Mechanisms of Fibrosis-Associated Promotion of Liver Carcinogenesis. Toxicological Sciences 132(1), 53-63 2013.
15. Cabibbo G., Maida M., Genco C., et al. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study W J Hepatol 2012 September 27; 4(9): 256-261.
16. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980; 46:372-9.
17. Honeyman JN, Simon EP, Robine N, et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science. (New York, NY). 2014; 343:1010-4.
18. Mittal S., and El-Serag HB. Epidemiology of HCC: Consider the Population. J Clin Gastroenterol. 2013; 47(0): S2-S6.
19. Yang JD, Kim WR, Coelho R, et al. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011; 9:64-70.
20. Hartwell HJ., Petrosky KY., Fox JG., et al. Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice. Proc. Natl Acad. Sci. USA (2014); 111, 11455-11460.
21. Xu L., Gao H., Huang J., et al. Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib. J of Gastroenterol and Hepatol 30 (2015) 1032-1039).
22. Trichopoulos D, Bamia C, Lagiou P, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 2011; 103: 1686-1695/
23. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007; 97: 1005-1008.
24. Scalera A, Tarantino G. Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol 2014; 20: 9217-9228.
25. Marrero J, Fontana R, Fu S, et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005;42:218-224.
26. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127.
Review
For citations:
Breder V.V. RISK FACTORS FOR HEPATOCELLULAR CANCER IN ONCOLOGY PRACTICE The experience of N. N. Blokhin Russian Cancer Research center. Experimental and Clinical Gastroenterology. 2016;(4):4-12. (In Russ.)
Views:
294
Email this article 